Dianthus Therapeutics | Betriebsergebnis



Operating Profit Veränderung Datum
Adcock Ingram Holdings ZAR 487.33M 8.25M 2024-12
Alaunos Therapeutics USD -755000 395K 2024-12
Avita Medical AUD -9957000 5.64M 2024-12
Celltrion KRW 242.47B 94.87B 2025-06
Cspc Pharmaceutical CNY 1.79B 940.51M 2025-03
Dianthus Therapeutics USD -31916000 2.02M 2024-12
Divis Laboratories Ltd 6.17B 1.62B 2025-06
IQVIA Holdings USD 556M 64M 2025-06
Kangmei Pharma CNY 13.09M 2.91M 2025-03
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Laboratorios Farma EUR 123.07M 85.91M 2024-12
Malin Corporation EUR -1100000 400K 2024-12
Medical Developments International AUD 182K 20.42M 2024-12
Moderna USD -907000000 143M 2025-06
Neuren Pharmaceuticals AUD 176.69M 166.79M 2024-12
Organigram Holdings CAD -11305000 11.59M 2024-12
Organon & Co USD 326M 225M 2025-06
Pharma Mar EUR 24.11M 27.19M 2025-06
Qiagen NV USD 135.97M 10.81M 2025-06
Revvity USD 90.76M 18.53M 2025-06
Sartorius EUR 161.8M 24.4M 2025-06
Sino Biopharmaceutical CNY 1.33B 2.53B 2024-12
Tectonic Therapeutic USD -13991000 5.65M 2024-12
Tilray USD -42218000 5.65M 2024-11
Viatris USD 185.4M 3.21B 2025-06
Xeris Pharmaceuticals USD 1.68M 14.57M 2024-12
Zz Pientze Pharmaceu 1.19B 803.71M 2025-03


Dianthus Therapeutics Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.